| abstract |
The present invention relates to a therapeutic combination for use as a medicament, wherein the therapeutic combination comprises: (a) a first pharmaceutical composition comprising a first proteinaceous molecule and at least one saponin covalently linked to said first proteinaceous molecule ; and (b) a second pharmaceutical composition comprising a second proteinaceous molecule comprising an effector moiety, wherein the binding site of the first proteinaceous molecule and the binding site of the second proteinaceous molecule are the same. The present invention also relates to a first pharmaceutical composition for use as a medicament. The present invention also relates to a first pharmaceutical composition further comprising a second proteinaceous molecule. The present invention also relates to a first pharmaceutical composition further comprising a second proteinaceous molecule, for use as a medicament. The present invention also relates to a first pharmaceutical composition further comprising a second proteinaceous molecule for use in the treatment or prevention of cancer in a patient in need thereof. |